Antibiotic resistance in sputum isolates of streptococcus pneumoniae in chronic obstructive pulmonary disease is related to antibiotic exposure

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 7, Issue 5, 2010, Pages 337-344

  Desai, Himanshu ^a   Richter, Sandra ^b   Doern, Gary ^b   Heilmann, Kris ^b   Dohrn, Cassie ^b   Johnson, Antoinette ^a   Brauer, Aimee ^c   Murphy, Timothy ^c   Sethi, Sanjay ^c  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antibiotic resistance; Beta Lactam; Chronic obstructive pulmonary disease; Macrolide; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; TETRACYCLINE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SPUTUM ANALYSIS; STREPTOCOCCUS PNEUMONIAE;

AGED; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PNEUMOCOCCAL INFECTIONS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM; STREPTOCOCCUS PNEUMONIAE;

EID: 77956978605     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2010.510162     Document Type: Article

References (44)

1. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008; 359(22):2355-2365.
2. Wilson R. The role of infection in COPD. Chest 1998; 113(4 Suppl):242S-248S.
3. White AJ, Gompertz S, Stockley RA. Chronic obstructive pulmonary disease 6: The aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax 2003; 58(1):73-80.
4. Murphy TF, Brauer AL, Eschberger K, Lobbins P, Grove L, Cai X, Sethi S. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177(8):853-860.
5. Fagon JY, Chastre J, Trouillet JL, Domart Y, Dombret MC, Bornet M, Gibert C. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis 1990; 142(5):1004-1008.
6. Monso E, Ruiz J, Rosell A, Manterola J, Fiz J, Morera J, Ausina V. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995; 152(4 Pt 1):1316-1320.
7. Murphy TF, Brauer AL, Grant BJ, Sethi S. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med 2005; 172(2):195-199.
8. Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347(7):465-471.
9. Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJ, Murphy TF. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000; 118(6):1557-1565.
10. Sethi S, Wrona C, Grant BJ, Murphy TF. Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169(4):448-453.
11. Soler N, Torres A, Ewig S, Gonzalez J, Celis R, El-Ebiary M, Hernandez C, Rodriguez-Roisin R. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998; 157(5 Pt 1):1498-1505.
12. White AJ, Gompertz S, Bayley DL, Hill SL, OBrien C, Unsal I, Stockley RA. Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax 2003; 58(8):680-685.
13. Zalacain R, Sobradillo V, Amilibia J, Barron J, Achotegui V, Pijoan JI, Llorente JL. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J 1999; 13(2):343-348.
14. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002; 57(9):759-764.
15. Jones ME, Karlowsky JA, Blosser-Middleton R, Critchley IA, Karginova E, Thornsberry C, Sahm DF. Longitudinal assessment of antipneumococcal susceptibility in the United States. Antimicrob Agents Chemother 2002; 46(8):2651-2655.
16. Mera RM, Miller LA, Daniels JJ, Weil JG, White AR. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project. Diagn Microbiol Infect Dis 2005; 51(3):195-200.
17. Reinert RR. Resistance phenotypes and multi-drug resistance in Streptococcus pneumoniae (PROTEKT years 1-3 (1999-2002). J Chemother 2004; 16 Suppl 6:35-48.
18. Bedos JP, Chevret S, Chastang C, Geslin P, Regnier B. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey. Clin Infect Dis 1996; 22(1):63-72.
19. Clavo-Sanchez AJ, Giron-Gonzalez JA, Lopez-Prieto D, Canueto-Quintero J, Sanchez-Porto A, Vergara-Campos A, Marin-Casanova P, Cordoba-Dona JA. Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrugresistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis 1997; 24(6):1052-1059.
20. Nava JM, Bella F, Garau J, Lite J, Morera MA, Marti C, Fontanals D, Font B, Pineda V, Uriz S et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994; 19(5):884-890.
21. Pallares R, Gudiol F, Linares J, Ariza J, Rufi G,Murgui L, Dorca J, Viladrich PF. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987; 317(1):18-22.
22. Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005; 40(9):1288-1297.
23. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152(5 Pt 2):S77-121.
24. Ertugrul N, Rodriguez-Barradas MC, Musher DM, Ryan MA, Agin CS, Murphy SJ, Shayegani M, Watson DA. BOX-polymerase chain reaction-based DNA analysis of nonserotypeable Streptococcus pneumoniae implicated in outbreaks of conjunctivitis. J Infect Dis 1997; 176(5):1401-1405.
25. Denys GA, Carey RB. Identification of Streptococcus pneumoniae with a DNA probe. J Clin Microbiol 1992; 30(10):2725-2727.
26. Mundy LS, Janoff EN, Schwebke KE, Shanholtzer CJ, Willard KE. Ambiguity in the identification of Streptococcus pneumoniae. Optochin, bile solubility, quellung, and the AccuProbe DNA probe tests. Am J Clin Pathol 1998; 109(1):55-61.
27. Whatmore AM, Efstratiou A, Pickerill AP, Broughton K, Woodard G, Sturgeon D, George R, Dowson CG. Genetic relationships between clinical isolates of Streptococcus pneumoniae, Streptococcus oralis, and Streptococcus mitis: characterization of "Atypical" pneumococci and organisms allied to S. mitis harboring S. pneumoniae virulence factor-encoding genes. Infect Immun 2000; 68(3):1374-1382.
28. McEllistrem MC, Stout JE, Harrison LH. Simplified protocol for pulsed-field gel electrophoresis analysis of Streptococcus pneumoniae. J Clin Microbiol 2000; 38(1):351-353.
29. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33(9):2233-2239.
30. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. In., 6th edn. Clinical and Laboratory Standards Institute; Wayne, PA, USA: 2003
31. Performance standards for antimicrobial susceptibility testing: 15th informational supplement. In Clinical and Laboratory Standards Institute; Wayne, PA, USA: 2005; M100-S115.
32. Performance standards for antimicrobial susceptibility testing: 18th informational supplement. In Clinical and Laboratory Standards Institute; Wayne, PA, USA: 2008; M100-S118.
33. MMWR. Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniaeUnited States, 20062007. MMWR Morb Mortal Wkly Rep 2008; 57(50):13531355.
34. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3(2):171-196.
35. Hofmann J, Cetron MS, Farley MM, Baughman WS, Facklam RR, Elliott JA, Deaver KA, Breiman RF. The prevalence of drugresistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995; 333(8):481-486.
36. Butler JC, Hofmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Preventions Pneumococcal Sentinel Surveillance System. J Infect Dis 1996; 174(5):986-993.
37. Moreno S, Garcia-Leoni ME, Cercenado E, Diaz MD, Bernaldo de Quiros JC, Bouza E. Infections caused by erythromycinresistant Streptococcus pneumoniae: incidence, risk factors, and response to therapy in a prospective study. Clin Infect Dis 1995; 20(5):1195-1200.
38. Reinert RR, Al-Lahham A, Lemperle M, Tenholte C, Briefs C, Haupts S, Gerards HH, Lutticken R. Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. J Antimicrob Chemother 2002; 49(1):61-68.
39. Seppala H, Nissinen A, Jarvinen H, Huovinen S, Henriksson T, Herva E, Holm SE, Jahkola M, Katila ML, Klaukka T et al. Resistance to erythromycin in group A streptococci. N Engl J Med 1992; 326(5):292-297.
40. Kelley MA, Weber DJ, Gilligan P, Cohen MS. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clin Infect Dis 2000; 31(4):1008-1011.
41. Daneman N, McGeer A, Green K, Low DE. Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin Infect Dis 2006; 43(4):432-438.
42. Robins-Browne RM, Kharsany AB, Koornhof HJ. Antibioticresistant pneumococci in hospitalized children. J Hyg (Lond) 1984; 93(1):9-16.
43. Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 1998; 113(6):1542-1548.
44. Miravitlles M, Espinosa C, Fernandez-Laso E, Martos JA, Maldonado JA, Gallego M. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD Study Group of Bacterial Infection in COPD. Chest 1999; 116(1):40-46.